Rockwell Medical (RMTI) Accounts Payables (2010 - 2026)

Rockwell Medical has reported Accounts Payables for 17 years, with the latest figure at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 79.01% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (up 79.01% YoY), and the FY2025 full-year result was $2.0 million, down 30.32% from the prior year.
• Accounts Payables for Q1 2026 stood at $3.4 million, up from $2.0 million in the prior quarter.
• The five-year high for Accounts Payables was $5.9 million in Q2 2023, with the low at $1.5 million in Q2 2025.
• Historically, Accounts Payables has averaged $3.4 million across 5 years, with a median of $3.3 million in 2024.
• Annual changes were most pronounced in 2023 — Accounts Payables jumped 101.46% — and 2025, when it slumped 60.87%.
• Rockwell Medical's Accounts Payables stood at $4.1 million in 2022, then advanced by 11.42% to $4.5 million in 2023, then sank by 36.47% to $2.9 million in 2024, then plunged by 30.32% to $2.0 million in 2025, then jumped by 72.39% to $3.4 million in 2026.
• The last three Accounts Payables figures came in at $3.4 million (Q1 2026), $2.0 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.